Genprex shares owned by Citadel Advisors
Quarter-by-quarter ownership of Genprex shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Genprex
Tip: Access up to 7 years of quarterly data
All positions including Genprex held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Genprex by Citadel Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $45k | 194k | 0.23 |
2023-09-30 | $7.0k | 18k | 0.39 |
2023-06-30 | $11k | 11k | 0.95 |
2023-03-31 | $49k | 54k | 0.91 |
2022-12-31 | $102k | 71k | 1.45 |
2022-06-30 | $73k | 52k | 1.40 |
2022-03-31 | $209k | 93k | 2.24 |
2021-12-31 | $136k | 103k | 1.32 |
2021-09-30 | $223k | 94k | 2.37 |
2021-06-30 | $293k | 87k | 3.36 |
2021-03-31 | $533k | 124k | 4.30 |
2020-12-31 | $465k | 112k | 4.15 |
2020-09-30 | $225k | 67k | 3.34 |
2020-06-30 | $198k | 63k | 3.14 |
2020-03-31 | $59k | 25k | 2.41 |
2019-06-30 | $39k | 32k | 1.24 |